CIK 0001070081
- Large accelerated filer
PTC THERAPEUTICS, INC.
Sign in to watch- Ticker
- PTCT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043416587
- Phone
- +1 908-222-7000
- Business address
- 500 WARREN CORPORATE CENTER DRIVE, WARREN, NJ, 07059
- Former names
- PTC THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,916,619
- in 9 filings, $5.9M under 10b5-1 plans
Net −$5,916,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-09-20 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion · Stock Option (Right to Buy) | −876 | $30.86 | $27K | 69,124 |
| 2022-09-20 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion · Stock Option (Right to Buy) | −300 | $30.86 | $9K | 68,824 |
| 2022-08-09 | Okey Stephanie Director | Sale | −2,296 | $51.62 | $119K | 1,867 |
| 2022-06-09 | Young Alethia Director | Grant or award | +3,200 | 3,200 | ||
| 2022-06-09 | Young Alethia Director | Grant or award | +1,867 | 5,067 | ||
| 2022-06-09 | Young Alethia Director | Grant or award · Stock Option (Right to Buy) | +12,000 | 12,000 | ||
| 2022-06-09 | Young Alethia Director | Grant or award · Stock Option (Right to Buy) | +7,000 | 7,000 | ||
| 2022-06-09 | Svoronos Dawn Director | Sale | −738 | $27.20 | $20K | 29,017 |
| 2022-06-07 | Peltz Stuart Walter CHIEF EXECUTIVE OFFICER | Sale | −407 | $26.83 | $11K | 38,239 |
| 2022-04-19 | Klein Matthew B. CHIEF OPERATING OFFICER | Sale | −897 | $42.52 | $38K | 56,564 |
| 2022-04-19 | Pauwels Eric CHIEF BUSINESS OFFICER | Sale | −822 | $42.52 | $35K | 49,772 |
| 2022-04-14 | Peltz Stuart Walter CHIEF EXECUTIVE OFFICER | Sale | −82 | $45.28 | $4K | 38,646 |
| 2022-04-13 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion | +2,276 | $11.23 | $26K | 63,386 |
| 2022-04-13 | Boulding Mark Elliott EXEC. VP AND CLO | Sale | −2,276 | $45.17 | $103K | 61,110 |
| 2022-04-13 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion · Stock Option (Right to Buy) | −2,276 | $11.23 | $26K | 0 |
| 2022-04-05 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion | +5 | $11.23 | $56 | 61,115 |
| 2022-04-05 | Boulding Mark Elliott EXEC. VP AND CLO | Sale | −5 | $45.00 | $225 | 61,110 |
| 2022-04-05 | Boulding Mark Elliott EXEC. VP AND CLO | Exercise or conversion · Stock Option (Right to Buy) | −5 | $11.23 | $56 | 2,276 |
| 2022-03-31 | Hill Emily Luisa CHIEF FINANCIAL OFFICER | Sale | −7,910 | $37.78 | $299K | 29,259 |
| 2022-02-10 | Boulding Mark Elliott Exec. VP and CLO | Exercise or conversion | +2,282 | $11.23 | $26K | 63,392 |
Page 46 of 53 · 1,049 trades